Matches in SemOpenAlex for { <https://semopenalex.org/work/W34319498> ?p ?o ?g. }
Showing items 1 to 83 of
83
with 100 items per page.
- W34319498 endingPage "150" @default.
- W34319498 startingPage "146" @default.
- W34319498 abstract "BACKGROUND: Particle size distribution in both HDL and LDL is reflected in the fractional esterification rate of cholesterol by lecithin cholesterol acyltransferase (LCAT) in plasma depleted of apoB containing lipoproteins (FER(HDL)). We studied FER(HDL) in a group of patients with type 2 diabetes and determined the impact of two different PPAR agonists (fenofibrate and rosiglitazone) on this marker of lipoprotein particle quality. PATIENTS AND METHODS: 66 patients with type 2 diabetes (26 women) and 32 control subjects (19 women) were included in the study. 33 patients received fenofibrate and 33 rosiglitazone as add on therapy. Average duration of treatment was 4 months. Plasma lipoprotein glucose levels were determined using an automated analyzer (COBAS Mira, Roche). LDL cholesterol concentrations were calculated by Friedewald formula. FER(HDL) was determined by a radioassay after precipitating apo-B containing particles of plasma. The assays were performed at baseline and at the end of each treatment. SPSS base program was used for statistical evaluation. RESULTS: Both fenofibrate and rosiglitazone resulted in a significant decrease of FER(HDL) (24.62 +/- 11.27%/h vs. 19.93 +/- 10.34%/h; 20.0 +/- 6.1%/h vs. 15.8 +/- 5.8%/h, p < 0.001). Rosiglitazone was significantly more effective in FER(HDL) lowering than fenofibrate (p < 0,02) CONCLUSIONS: Both fenofibrate and rosiglitazone improve FER(HDL) in patients with type 2 diabetes. The effect is more pronounced for rosiglitazone. Qualitative change of plasma lipoproteins reflected by FER(HDL) can contribute to antiatherogenic action of PPAR agonists. On contrary, changes of lipoprotein composition induced by PPAR agonists cannot explain adverse cardiovascular effects observed in some large clinical trials with PPAR agonists." @default.
- W34319498 created "2016-06-24" @default.
- W34319498 creator A5006909917 @default.
- W34319498 creator A5017005943 @default.
- W34319498 creator A5023490191 @default.
- W34319498 creator A5038958416 @default.
- W34319498 creator A5048171156 @default.
- W34319498 creator A5052813977 @default.
- W34319498 creator A5066359969 @default.
- W34319498 creator A5086863186 @default.
- W34319498 date "2008-02-01" @default.
- W34319498 modified "2023-10-18" @default.
- W34319498 title "Fenofibrate and rosiglitazone improve quality of lipoproteins in patients with type 2 diabetes mellitus." @default.
- W34319498 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/18283261" @default.
- W34319498 hasPublicationYear "2008" @default.
- W34319498 type Work @default.
- W34319498 sameAs 34319498 @default.
- W34319498 citedByCount "0" @default.
- W34319498 crossrefType "journal-article" @default.
- W34319498 hasAuthorship W34319498A5006909917 @default.
- W34319498 hasAuthorship W34319498A5017005943 @default.
- W34319498 hasAuthorship W34319498A5023490191 @default.
- W34319498 hasAuthorship W34319498A5038958416 @default.
- W34319498 hasAuthorship W34319498A5048171156 @default.
- W34319498 hasAuthorship W34319498A5052813977 @default.
- W34319498 hasAuthorship W34319498A5066359969 @default.
- W34319498 hasAuthorship W34319498A5086863186 @default.
- W34319498 hasConcept C126322002 @default.
- W34319498 hasConcept C134018914 @default.
- W34319498 hasConcept C185592680 @default.
- W34319498 hasConcept C2777180221 @default.
- W34319498 hasConcept C2778110834 @default.
- W34319498 hasConcept C2778163477 @default.
- W34319498 hasConcept C2778913445 @default.
- W34319498 hasConcept C2780072125 @default.
- W34319498 hasConcept C2780152017 @default.
- W34319498 hasConcept C555293320 @default.
- W34319498 hasConcept C62746215 @default.
- W34319498 hasConcept C71924100 @default.
- W34319498 hasConceptScore W34319498C126322002 @default.
- W34319498 hasConceptScore W34319498C134018914 @default.
- W34319498 hasConceptScore W34319498C185592680 @default.
- W34319498 hasConceptScore W34319498C2777180221 @default.
- W34319498 hasConceptScore W34319498C2778110834 @default.
- W34319498 hasConceptScore W34319498C2778163477 @default.
- W34319498 hasConceptScore W34319498C2778913445 @default.
- W34319498 hasConceptScore W34319498C2780072125 @default.
- W34319498 hasConceptScore W34319498C2780152017 @default.
- W34319498 hasConceptScore W34319498C555293320 @default.
- W34319498 hasConceptScore W34319498C62746215 @default.
- W34319498 hasConceptScore W34319498C71924100 @default.
- W34319498 hasIssue "1" @default.
- W34319498 hasLocation W343194981 @default.
- W34319498 hasLocation W343194982 @default.
- W34319498 hasOpenAccess W34319498 @default.
- W34319498 hasPrimaryLocation W343194981 @default.
- W34319498 hasRelatedWork W1974919255 @default.
- W34319498 hasRelatedWork W1984569423 @default.
- W34319498 hasRelatedWork W1986438251 @default.
- W34319498 hasRelatedWork W2001680929 @default.
- W34319498 hasRelatedWork W2003731317 @default.
- W34319498 hasRelatedWork W2006563824 @default.
- W34319498 hasRelatedWork W2050336356 @default.
- W34319498 hasRelatedWork W2105342032 @default.
- W34319498 hasRelatedWork W2125934070 @default.
- W34319498 hasRelatedWork W2131215476 @default.
- W34319498 hasRelatedWork W2146992882 @default.
- W34319498 hasRelatedWork W2148459936 @default.
- W34319498 hasRelatedWork W2152211449 @default.
- W34319498 hasRelatedWork W2312230170 @default.
- W34319498 hasRelatedWork W2410064838 @default.
- W34319498 hasRelatedWork W2414936277 @default.
- W34319498 hasRelatedWork W2610097180 @default.
- W34319498 hasRelatedWork W2732519495 @default.
- W34319498 hasRelatedWork W2742604884 @default.
- W34319498 hasRelatedWork W2951669341 @default.
- W34319498 hasVolume "29" @default.
- W34319498 isParatext "false" @default.
- W34319498 isRetracted "false" @default.
- W34319498 magId "34319498" @default.
- W34319498 workType "article" @default.